Rxclinicalsolutions Ltd
- Active
- Small
- 2 years
- 1m-15m
- Real address
- 1 director
- 1 owner
- Solo founder
- London
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
Rxclinicalsolutions Ltd is a private limited company registered in England/Wales with the registration number 15396607. The company was founded two years ago on January 08, 2024, and registered at W1T 2EW, United Kingdom, London, 60 Tottenham Court Road, Suite 4063a, Fitzrovia. The address is probably real as only one company are registered at the same address. Its status is active. The company operates in the retail, the professional services, the health & social care, the professional services n.e.c., the pharmacy, the other health services industries. Officially, it has one owner or PSCs, one director and no number of employees published.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 2 years
- 75%+
-
Resident of United Kingdom
Managers
-
Individual
- 2 years
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted four months ago.
Last news
-
Registered office address changed from Suite 4063 Unit 3a 34-35 Hatton Garden Holborn London EC1N 8DX United Kingdom to 60 Tottenham Court Road, Suite 4063a Fitzrovia London W1T 2EW on 2026-05-21Download 1 page pdf report
-
Confirmation statement made on 2026-01-07 with no updatesDownload 3 pages pdf report
-
Total exemption full accounts made up to 2025-01-31Download 7 pages pdf report
FAQ about Rxclinicalsolutions Ltd
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.